(9.00 – 9.45 Registration & Introduction)

 

9.45 – 11.00 Professor Dale Bredesen

 

Professor Bredesen, Augustus Rose, Professor at UCLA and Founding President of the Buck Institute for Research on Aging, has spent over 30 years researching the treatment and prevention of Alzheimer’s disease and is an acknowledged leader in the field of Alzheimer’s research. Professor Bredesen trained with Nobel laureate Prof. Stanley Prusiner, and has published over 200 papers focused on the mechanisms and treatment of neurodegenerative disease.

Professor Bredesen’s research has led to new insights that explains the erosion of memory seen in Alzheimer’s disease, and has opened the door to a new therapeutic approach revolved around diet and lifestyle, known as The Bredesen Protocol™.

 In October 2014 the first success in reversing cognitive decline in early Alzheimer’s disease and its precursors, MCI and SCI, was reported (Bredesen, Impact Aging 2014).  This anecdotal study reported the initial 10 patients treated with a novel, programmatic approach. And now over 100 patients have been treated, with unprecedented results.

Professor Bredesen will review the scientific basis and unprecedented clinical results of this multi-factorial lifestyle and nutrition based approach to treating, and reversing, early onset Alzheimer’s.

 

(11.00 -11.15 Break)

 

11.15 – 12.00 Amanda Williams, PgDip Nutritional Therapy, DipAIT, RANA, Dip NLP, mBANT, rCNHC

 

Amanda Williams has been with Cytoplan for 18 years, as Managing Director for the last 11 years. A qualified registered nutritional therapist, Amanda has 40 years of experience within the field of Nutrition, having worked in health/nutrition-related fields for most of her working life.

Amanda and her team are in collaboration with Professor Bredesen and his US team and are bringing his work to the UK to help treat people with Alzheimer’s disease in conjunction with a team of doctors and health professionals. In her talk Amanda will review the role of nutritional supplements, diet and lifestyle interventions that support The Bredesen Protocol™.

 

12.00 – 12.30 Clare Daley, BSc (Hons), PgDip Nutritional Therapy, mBANT, rCNHC

 

Clare has a degree in Biological Sciences and a Postgraduate Diploma in Nutritional Therapy. Since qualifying in 2010 Clare has worked as a Nutritional Therapist, joining the team at Cytoplan, in 2015 providing support to both student and qualified practitioners. Clare became interested in Nutrigenomics several years ago and since then has attended a number of courses and used genetic testing in her practice.

Clare will discuss the ‘Genetics of Alzheimer’s’ explaining some of the genetic polymorphisms relevant to Alzheimer’s and how they contribute to its pathology. There is already an increasing body of research available looking at how expression of these genes can be supported through diet and lifestyle interventions. The ApoE4 gene is associated with an increased Alzheimer’s risk, but there are in fact over 200 other genes which may also increase the risk.

 

1.30 – 2.30 Laura Stirling, Dip BCNH, mBANT, mIFM, rCNHC

 

Laura Stirling of Regenerus Laboratories will discuss the clinical relevance of Cyrex testing and its place in neurological conditions, linking gut health, inflammation of brain tissue, and associations with some dietary proteins.

Laura works as part of practitioner support with Regenerus. With over 9 years of experience in supporting functional laboratory diagnostics and the clinical utility of testing, Laura is able to support practitioners with their choice of testing and the application of test results.

 

2.30 – 3.45 Lucille Leader, Dip ION, NTCC, rCNHC

 

Lucille Leader is the Nutritional Director of The Multidisciplinary London Pain Relief and Nutritional Support Clinic under the leadership of Dr Geoffrey Leader, which includes the pioneering Parkinson’s Disease Multidisciplinary Management Clinic at Highgate Hospital in London.

The metabolic aspects of Dopamine Metabolism and its aberrance in this neuro-degenerative  disease,  will be presented by Lucille in her talk.  Other metabolic pathways which are implicated in non-motor pathogeneses in Parkinson’s Disease will be described including inflammatory prostaglandins, oxidative stress, mitochondrial function, methylation, intestinal status and function.

Biochemical tests to establish cellular status and nutritional therapeutic potential will be recommended, as well as appropriate nutritional supplements and protocols to reduce drug-nutrient interactions and side-effects of medication.  Dopaminergic drugs will be briefly reviewed.

The role of the Nutritional Therapist as a co-ordinator between the GP, the patient and various health specialists to provide optimum care, will be discussed.

 

(3.45 – 4.15 Break)

 

4.15 – 5.15 Miguel Toribio-Mateas, MSc, BSc (Hons), PgDip, FBANT, NTCC, rCNHC

 

Miguel was born in Madrid to an Andalusian family, and lived there until he moved to London in 1994 at the age of 21. In his talk Miguel will draw from his own first hand experience of the Mediterranean diet, as well as from his recent research experience on neuroprotection. He will translate the benefits of a Mediterranean-style diet into an evidence-based model for brain protection and cognitive enhancement that includes both foods and multiple food supplements.

Miguel is a leading lecturer, author and researcher who specialises in clinical neuroscience and healthy ageing, a popular subject he’s covered in peer reviewed publications and international events, from London to Silicon Valley. He is Chairman of BANT.

 

5.15 – Q&A Session